ScinnoHub Pharmaceutical Co., Ltd.

Quick facts

Phase 1 pipeline

• BT-114143
• BT-114143 Injection at High-dose
• BT-114143 Injection at low dose
• BT-114143 Injection at Medium-dose
• SNH-119014

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• ScinnoHub Pharmaceutical Co., Ltd. portfolio CI brief
• ScinnoHub Pharmaceutical Co., Ltd. pipeline updates RSS